1. From the Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; 2These authors contributed equally to the work presented here and should therefore be regarded as equivalent authors.
2. the Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts; the 4Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts; 2These authors contributed equally to the work presented here and sho
3. the Centre for Molecular Epidemiology and
4. the Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington;
5. the Departments of Medicine, 8Epidemiology and Public Health, and the 9Duke-National University of Singapore Graduate Medical School, Singapore;
6. the Singapore Eye Research Institute, Singapore National Eye Centre, Singapore;
7. the Centre for Vision Research, University of Sydney, Sydney, New South Wales, Australia; the 12Centre for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia;
8. the Centre for Vision Research, University of Sydney, Sydney, New South Wales, Australia;
9. the Division of Nephrology, Department of Medicine, Helsinki University, Helsinki, Finland; the 14Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland;
10. the Biomedical Research Institute, University of Dundee, Dundee, Scotland, United Kingdom;
11. the Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; the 16Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland;
12. the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio;
13. the Neurobiology Neurodegeneration and Repair Laboratory and
14. the Laboratory for DNA Analysis and Molecular Diagnostics, Department of Nephrology, Medical University of Lublin, Lublin, Poland;
15. the Icelandic Heart Association, Kopavogur, Iceland; the 22University of Iceland, Reykjavik, Iceland;
16. the Department of Medicine and Therapeutics, Population Pharmacogenetics Group, Ninewells Hospital and Medical School, Dundee, Scotland, United Kingdom;
17. the Departments of Medicine,
18. Physiology and Biophysics,
19. the Departments of Medicine, 27Biostatistics, and
20. Ophthalmology, University of Mississippi Medical Center, Jackson, Mississippi;
21. Epidemiology and Public Health, and
22. Ophthalmology, National University of Singapore, Singapore; the 10Singapore Eye Research Institute, Singapore National Eye Centre, Singapore;
23. the Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; and
24. the Medical Genetics Institute, Cedar-Sinai Medical Center, Los Angeles, California.
25. the Division of Epidemiology and Clinical Applications, Intramural Research Program, National Eye Institute, National Institutes of Health, Bethesda, Maryland;
26. Ophthalmology, National University of Singapore, Singapore; the 10Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; the 12Centre for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia;